Yield10 Bioscience announces pricing of $2.9 million registered direct offering
Yield10 Bioscience announced a securities purchase agreement with certain institutional investors and existing investor Jack W. Schuler, providing for the purchase and sale of 2,421,662 shares of common stock at $1.2101 per share in a registered direct offering with gross proceeds of $2.9 million. March 15, 2019